Company intelligence / Profile preview

Obsurge Biotech

New Delhi, Delhi, Indiaobsurge.com ↗

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Obsurge Biotech is an Indian pharmaceutical company focused on developing, manufacturing, and marketing a diverse range of healthcare products. The company specializes in therapeutic segments such as gynecology, orthopedics, gastroenterology, and pediatrics, providing both prescription medicines and nutraceutical supplements. Obsurge Biotech is known for its commitment to quality and affordability, maintaining a significant presence in the Indian domestic market through a robust distribution network. Their product portfolio includes treatments for bone health, iron deficiency, and various maternal health conditions.

Therapeutic areas: HematologyEndocrinologyWomen's HealthGastroenterology
Modalities: Small moleculeNutraceutical
Industry: Biotech

Drug pipeline

1 asset

Imusurge

Unknown

Beyond the preview

Go deeper on Obsurge Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Obsurge Biotech.

Explore the full profile